Cargando…

Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare

BACKGROUND: Equine endometrosis is a chronic degenerative condition, described as endometrial fibrosis that forms in the stroma, under the basement membrane and around the endometrial glands. The role of lysophosphatidic acid (LPA) in the development of tissue fibrosis varies depending on the organ,...

Descripción completa

Detalles Bibliográficos
Autores principales: Szóstek-Mioduchowska, Anna, Leciejewska, Natalia, Zelmańska, Beata, Staszkiewicz-Chodor, Joanna, Ferreira-Dias, Graça, Skarzynski, Dariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499873/
https://www.ncbi.nlm.nih.gov/pubmed/32943074
http://dx.doi.org/10.1186/s12917-020-02562-6
_version_ 1783583754800857088
author Szóstek-Mioduchowska, Anna
Leciejewska, Natalia
Zelmańska, Beata
Staszkiewicz-Chodor, Joanna
Ferreira-Dias, Graça
Skarzynski, Dariusz
author_facet Szóstek-Mioduchowska, Anna
Leciejewska, Natalia
Zelmańska, Beata
Staszkiewicz-Chodor, Joanna
Ferreira-Dias, Graça
Skarzynski, Dariusz
author_sort Szóstek-Mioduchowska, Anna
collection PubMed
description BACKGROUND: Equine endometrosis is a chronic degenerative condition, described as endometrial fibrosis that forms in the stroma, under the basement membrane and around the endometrial glands. The role of lysophosphatidic acid (LPA) in the development of tissue fibrosis varies depending on the organ, and its profibrotic role in mare endometrosis remains unclear. The study aimed to establish the endometrial presence of LPA and its receptors (LPAR1–4), together with its effects on connective tissue growth factor (CTGF) and prostaglandins (PG) secretion from equine endometrium under physiological (estrous cycle), or pathological conditions (endometrosis). Mare endometria in the mid-luteal phase (n = 5 for each category I, IIA, IIB, III of Kenney and Doig) and in the follicular phase (n = 5 for each category I, IIA, III and n = 4 for IIB) were used. In experiment 1, the levels of LPA, LPAR1–4 mRNA level and protein abundance were investigated in endometria at different stages of endometrosis. In experiment 2, the in vitro effect of LPA (10(− 9) M) on the secretion of CTGF and PGs from endometrial tissue explants at different stages of endometrosis were determined. RESULTS: Endometrial LPA concentration was higher in the mid-luteal phase compared to the follicular phase in category I endometrium (P < 0.01). There was an alteration in endometrial concentrations of LPA and LPAR1–4 protein abundance in the follicular phase at different stages of endometrosis (P < 0.05). Additionally, LPA increased the secretion of PGE(2) from category I endometrium in both phases of the estrous cycle (P < 0.05). The effect of LPA on the secretion of CTGF and PGF(2α) from endometrial tissue was altered depending on different stages of endometrosis (P < 0.05). CONCLUSION: Our data indicate that endometrosis disturbs proper endometrial function and is associated with altered endometrial LPA concentration, its receptor expression and protein abundance, PGE(2)/PGF(2α) ratio, and CTGF secretion in response to LPA. These changes could influence several physiological events occurring in endometrium in mare during estrous cycle and early pregnancy.
format Online
Article
Text
id pubmed-7499873
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74998732020-09-21 Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare Szóstek-Mioduchowska, Anna Leciejewska, Natalia Zelmańska, Beata Staszkiewicz-Chodor, Joanna Ferreira-Dias, Graça Skarzynski, Dariusz BMC Vet Res Research Article BACKGROUND: Equine endometrosis is a chronic degenerative condition, described as endometrial fibrosis that forms in the stroma, under the basement membrane and around the endometrial glands. The role of lysophosphatidic acid (LPA) in the development of tissue fibrosis varies depending on the organ, and its profibrotic role in mare endometrosis remains unclear. The study aimed to establish the endometrial presence of LPA and its receptors (LPAR1–4), together with its effects on connective tissue growth factor (CTGF) and prostaglandins (PG) secretion from equine endometrium under physiological (estrous cycle), or pathological conditions (endometrosis). Mare endometria in the mid-luteal phase (n = 5 for each category I, IIA, IIB, III of Kenney and Doig) and in the follicular phase (n = 5 for each category I, IIA, III and n = 4 for IIB) were used. In experiment 1, the levels of LPA, LPAR1–4 mRNA level and protein abundance were investigated in endometria at different stages of endometrosis. In experiment 2, the in vitro effect of LPA (10(− 9) M) on the secretion of CTGF and PGs from endometrial tissue explants at different stages of endometrosis were determined. RESULTS: Endometrial LPA concentration was higher in the mid-luteal phase compared to the follicular phase in category I endometrium (P < 0.01). There was an alteration in endometrial concentrations of LPA and LPAR1–4 protein abundance in the follicular phase at different stages of endometrosis (P < 0.05). Additionally, LPA increased the secretion of PGE(2) from category I endometrium in both phases of the estrous cycle (P < 0.05). The effect of LPA on the secretion of CTGF and PGF(2α) from endometrial tissue was altered depending on different stages of endometrosis (P < 0.05). CONCLUSION: Our data indicate that endometrosis disturbs proper endometrial function and is associated with altered endometrial LPA concentration, its receptor expression and protein abundance, PGE(2)/PGF(2α) ratio, and CTGF secretion in response to LPA. These changes could influence several physiological events occurring in endometrium in mare during estrous cycle and early pregnancy. BioMed Central 2020-09-17 /pmc/articles/PMC7499873/ /pubmed/32943074 http://dx.doi.org/10.1186/s12917-020-02562-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Szóstek-Mioduchowska, Anna
Leciejewska, Natalia
Zelmańska, Beata
Staszkiewicz-Chodor, Joanna
Ferreira-Dias, Graça
Skarzynski, Dariusz
Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare
title Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare
title_full Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare
title_fullStr Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare
title_full_unstemmed Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare
title_short Lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare
title_sort lysophosphatidic acid as a regulator of endometrial connective tissue growth factor and prostaglandin secretion during estrous cycle and endometrosis in the mare
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499873/
https://www.ncbi.nlm.nih.gov/pubmed/32943074
http://dx.doi.org/10.1186/s12917-020-02562-6
work_keys_str_mv AT szostekmioduchowskaanna lysophosphatidicacidasaregulatorofendometrialconnectivetissuegrowthfactorandprostaglandinsecretionduringestrouscycleandendometrosisinthemare
AT leciejewskanatalia lysophosphatidicacidasaregulatorofendometrialconnectivetissuegrowthfactorandprostaglandinsecretionduringestrouscycleandendometrosisinthemare
AT zelmanskabeata lysophosphatidicacidasaregulatorofendometrialconnectivetissuegrowthfactorandprostaglandinsecretionduringestrouscycleandendometrosisinthemare
AT staszkiewiczchodorjoanna lysophosphatidicacidasaregulatorofendometrialconnectivetissuegrowthfactorandprostaglandinsecretionduringestrouscycleandendometrosisinthemare
AT ferreiradiasgraca lysophosphatidicacidasaregulatorofendometrialconnectivetissuegrowthfactorandprostaglandinsecretionduringestrouscycleandendometrosisinthemare
AT skarzynskidariusz lysophosphatidicacidasaregulatorofendometrialconnectivetissuegrowthfactorandprostaglandinsecretionduringestrouscycleandendometrosisinthemare